Ubie Raises $125M to Transform Global Healthcare with AI-Driven Symptom Checker Innovation

Ubie, the global health-tech trailblazer, is thrilled to announce a new funding milestone of $125 million, a testament to its innovative approach and unwavering commitment to transforming healthcare worldwide. Founded by a visionary medical doctor and an engineer, Ubie leverages its unparalleled disease prediction AI to set new benchmarks in the field, offering an AI-powered symptom checker that engages over 10 million monthly active users. This breakthrough technology guides more than 7 million patients every month toward making informed decisions about their health. Headquartered in bustling hubs like New York, Tokyo, and Singapore, Ubie has not only attained international acclaim—most notably being recognized as LinkedIn’s fastest-growing startup in Japan for 2021—but also built a solid reputation for precision and reliability. The recent infusion of $125 million is strategically designated to accelerate the development and expansion of Ubie’s next-generation SaaS solutions, empowering over 1500 healthcare provider organizations to enhance operational efficiency and refine their triaging processes. Moreover, this capital will further fuel Ubie’s strategic partnerships with over half of the world’s mega-pharma companies, reinforcing its position as an influential force in the global healthcare landscape. With robust backing from prestigious partners such as IDEO and Design for Ventures, Ubie is poised to revolutionize patient care and clinician support systems on an unprecedented scale. We invite you to explore Ubie’s cutting-edge AI Symptom Checker and witness firsthand how technology is reshaping the future of healthcare at https://ubiehealth.com/.